Marine cyanobacteria—a prolific source of natural products
By A. Burja, B. Banaigs, E. Abou-Mansour, J. Burgess, P. Wright. 2001
756 citations recorded by the source corpus.
Subfields: Biotechnology, Environmental Chemistry, Renewable Energy, Sustainability and the Environment
View Paper: https://www.semanticscholar.org/paper/c062ad971944bc631f22bc143636b7e6cff3cb8d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Environmental Chemistry
In Renewable Energy, Sustainability and the Environment
- N. Biondi
- M. Tredici
- S. P. Tiwari
- R. Luque
- Rajeshwar Prasad Sinha
- Uttam Chand Banerjee
- Soha S. M. Mostafa
- Keshwanand Tripathi
Citations in the corpus
- Bioactive Compounds from Cyanobacteria and Microalgae: An Overview (2005, background): “lipopeptides include different compounds like cytotoxic (41%), antitumor (13%), antiviral (4%), antibiotics (12%) and the remaining 18% activities include antimalarial, antimycotics, multi-drug resistance reversers, antifeedant, herbicides and immunosuppressive agents (Figure 4) (Burja et al., 2001)”
- Microalgae cultivation and metabolites production: a comprehensive review (2018, background): “…molecular degeneration may result because of insuffi cient dietary ingestion.171,172 Microalgal biomass is also a rich source of vitamin A, C, D and E. Burja et al. (2001) reviewed the anti-biotic and anti-mycotic activities of microalgal compounds.173 Some proteins from marine microalgae have…”
- Cyanobacterial peptides - nature's own combinatorial biosynthesis. (2006, background): “Cyanobacterial secondary metabolites represent a vast diversity of structures (Moore, 1996; Burja et al., 2001; Staunton & Weissman, 2001; Harrigan & Goetz, 2002) isolated from a variety of taxa and geographic origins.”
- POLYPHASIC STUDY OF ANTARCTIC CYANOBACTERIAL STRAINS 1 (2006, background): “…the search for bioactive products from cyanobacteria (i.e. antitumor, antifungal, antibacterial, and antiviral molecules) has intensified during recent decades (Burja et al. 2001), until this study, there has not been a pharmaceutical screening of a significant number of Antarctic cyanobacteria.”
- Role of Lipids and Fatty Acids in Stress Tolerance in Cyanobacteria (2002, background): “Cyanovirin (CV-N, cyanovirin-N), a 101 amino acid protein extracted from Nostoc ellipsosporum was found to have potent activity against all immunodeficiency viruses such as HIV-1, M-and T-tropic stains of HIV-1, HIV-2, SIV (simian) and FIV (feline) (for a review see Burja et al. 2001).”
- Effectiveness of cyanobacteria and green algae in enhancing the photosynthetic performance and growth of willow (Salix viminalis L.) plants under limited synthetic fertilizers application (2017, result): “Our results are in line with the studies of other researchers (Falch et al. 1995, Kreitow et al. 1999, Burja et al. 2001, Nain et al. 2010, and Rana et al. 2012) who demonstrated the stimulatory influence of green-blue algae on wheat development and their inhibitory effect on Fig.”
- The promising future of microalgae: current status, challenges, and optimization of a sustainable and renewable industry for biofuels, feed, and other products (2018, background): “These toxic substances also have important antibacterial and antifungal activities [211, 212].”
- Sustainability and cyanobacteria (blue-green algae): facts and challenges (2011, background): “Also, they may be used as a source of natural chemicals to substitute synthetic cosmetics (Burja et al. 2001; Singh et al. 2005) and conventional energy resources (Deng and Coleman 1999; Dutta et al.”
- Cyanobacteria: A Precious Bio-resource in Agriculture, Ecosystem, and Environmental Sustainability (2016, neutral): “These bioactive compounds belong to the group of polyketides, amides, alkaloids, fatty acids, indoles, and lipopeptides (Abarzua et al., 1999; Burja et al., 2001).”
- Microalgal Biotechnology: Prospects and Applications (2012, background): “Cyanobacterial lipopeptides include different compounds like cytotoxic (41%), antitumor (13%), antiviral (4%), antibiotics (12%) and the remaining 18% activities include antimalarial, antimycotics, multi-drug resistance reversers, antifeedant, herbicides and immunosuppressive agents [7]; besides the”